By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


W. L. Gore & Associates, Inc. 

Newark  Delaware    U.S.A.
Phone: 888-914-4673 Fax:


Medical Device

Company News
ViaCyte And W. L. Gore & Associates Announce Collaborative Research Agreement To Develop Novel Implantable Delivery Technologies For Cell Therapies 3/29/2017 8:27:54 AM
W. L. Gore & Associates Unveils Next Evolution For TIPS Procedures: Lasting Diameter Control 3/9/2017 6:07:10 AM
W. L. Gore & Associates Release: GORE TIGRIS Vascular Stent Gains Health Canada Approval For Treatment Of Peripheral Artery Disease 3/6/2017 10:46:33 AM
W. L. Gore & Associates Snags FDA Nod for First Balloon Expandable Stent Graft for Use in the Iliac Artery 1/30/2017 6:36:40 AM
W. L. Gore & Associates Release: Device Company Announces Launch Of GORE Protein Capture Device With Protein A For Rapid mAb Purification At PepTalk 1/10/2017 11:16:11 AM
W. L. Gore & Associates Receives Innovative Technology Designation From Vizient For Gore Synecor Biomaterial 12/15/2016 10:52:45 AM
W. L. Gore & Associates Global Registry For Endovascular Aortic Treatment Completes Enrollment 11/15/2016 12:49:11 PM
New Technology Add-On Payment Awarded For W. L. Gore & Associates EXCLUDER Iliac Branch Endoprosthesis 9/27/2016 10:47:40 AM
W. L. Gore & Associates Release: One-Year Results In Japanese Clinical Study Affirms The GORE VIABAHN Endoprosthesis As A Device-Of-Choice For Treating Complex SFA Disease 9/20/2016 10:42:33 AM
W. L. Gore & Associates Release: First Implant Completed In Pivotal Study Of GORE TAG Thoracic Branch Endoprosthesis 9/19/2016 11:24:18 AM